Literature DB >> 9519261

Preischemic hyperglycemia leads to rapidly developing brain damage with no change in capillary patency.

P A Li1, J Vogel, Q P He, M L Smith, W Kuschinsky, B K Siesjö.   

Abstract

The present experiments were undertaken to explore whether exaggeration of ischemic brain damage by preischemic hyperglycemia is due to lack of capillary patency in the postischemic period. Normo- and hyperglycemic rats were exposed to 10 min of forebrain ischemia. Histopathological changes were evaluated after 6 and 16-18 h of recovery by light microscopy, and capillary patency was assessed at the same time points by a double-staining technique, depicting perfused and morphologically identifiable capillaries. The results demonstrate that some neuronal damage was detectable after 6 h of recirculation which was aggravated after 16-18 h of recirculation in hyperglycemic rats. In contrast, the degree of capillary patency was similar in normo- and hyperglycemic rats. In both groups the perfusion marker, Evans blue, perfused about 95% of all capillaries when injected 10 s before decapitation. Since preischemic hyperglycemia exaggerates brain damage without cessation of capillary perfusion the primary targets of hyperglycemic brain damage may not be capillaries but neurons or glial cells.

Entities:  

Mesh:

Year:  1998        PMID: 9519261     DOI: 10.1016/s0006-8993(97)01150-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Acute hyperglycemia together with hematoma of high-glucose blood exacerbates neurological injury in a rat model of intracerebral hemorrhage.

Authors:  Rong-Yi Liu; Jun-Jun Wang; Xia Qiu; Ji-Min Wu
Journal:  Neurosci Bull       Date:  2013-07-25       Impact factor: 5.203

Review 2.  Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis.

Authors:  Niall J J MacDougall; Keith W Muir
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-15       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.